Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Fortis Dengue Case: NPPA seeks bill copies from hospital

      Fortis Dengue Case: NPPA seeks bill copies from hospital

      Ruby Khatun Khatun25 Nov 2017 9:15 AM IST
      New Delhi: The National Pharmaceutical Pricing Authority (NPPA) asked Fortis Healthcare to provide copies of bills in relation to the case of alleged...
      Cancer, cardiac among 51 essential drugs under NPPA price cap, check out details

      Cancer, cardiac among 51 essential drugs under NPPA price cap, check out details

      Ruby Khatun Khatun24 Nov 2017 4:15 PM IST
      New Delhi: National drug pricing regulator NPPA on Friday said it has capped prices of 51 essential formulations, including those used for the...
      Zydus Cadila gets USFDA nod to sell erectile dysfunction drug

      Zydus Cadila gets USFDA nod to sell erectile dysfunction drug

      Ruby Khatun Khatun24 Nov 2017 11:05 AM IST
      New Delhi: Drug firm Zydus Cadila said it has received approval from the US health regulator to market Tadalafil tablets, used for the treatment of...
      FDA approves first two-drug HIV regimen from GSK

      FDA approves first two-drug HIV regimen from GSK

      Ruby Khatun Khatun24 Nov 2017 10:37 AM IST
      NEW YORK: The U.S. Food and Drug Administration (FDA) on Tuesday approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed...
      Virinchi Hospitals partners with MedGenome to offer Molecular diagnostics

      Virinchi Hospitals partners with MedGenome to offer Molecular diagnostics

      Ruby Khatun Khatun24 Nov 2017 10:17 AM IST
      Hyderabad: Virinchi Hospitals, a subsidiary of Hyderabad-based IT company Virinch Limited has partnered with MedGenome, a genomics-based diagnostics...
      Biocon launches colon cancer drug in India, priced Rs 24,000

      Biocon launches colon cancer drug in India, priced Rs 24,000

      Ruby Khatun Khatun24 Nov 2017 10:01 AM IST
      Bengaluru: Biocon Ltd has launched KRABEVA, a biosimilar Bevacizumab for the treatment of patients with metastatic colorectal cancer and other types...
      Roche, AbbVie leukemia drug superior to older medicine in study

      Roche, AbbVie leukemia drug superior to older medicine in study

      Ruby Khatun Khatun24 Nov 2017 9:45 AM IST
      Patients with a type of leukemia that had relapsed who received the new drug Venclexta in combination with Rituxan went significantly longer without...
      Under pressure in diabetes, Novo Nordisk steps up focus on obesity drugs

      Under pressure in diabetes, Novo Nordisk steps up focus on obesity drugs

      Ruby Khatun Khatun24 Nov 2017 9:30 AM IST
      Denmark: Danish drugmaker Novo Nordisk is stepping up its efforts to treat obesity, seeking to tap into a potentially huge market as prices for its...
      Misuse of Topical Steroid Skin Creams: Delhi HC notice to CDSCO

      Misuse of Topical Steroid Skin Creams: Delhi HC notice to CDSCO

      Ruby Khatun Khatun23 Nov 2017 12:37 PM IST
      New Delhi: The Delhi High Court on Wednesday sought the Centre's response on a plea seeking direction to ensure that no topical medications which...
      Strides Shasun gets USFDA nod for altitude sickness tablets

      Strides Shasun gets USFDA nod for altitude sickness tablets

      Ruby Khatun Khatun23 Nov 2017 10:30 AM IST
      Bangalore: Strides Shasun Limited announced that it's wholly owned subsidiary Strides Pharma Global Pte. Ltd. has received approval from the United...
      Ajanta Pharma launches generic ADHD treatment drug in US

      Ajanta Pharma launches generic ADHD treatment drug in US

      Ruby Khatun Khatun23 Nov 2017 10:15 AM IST
      New Delhi: Drug firm Ajanta Pharma said it has launched generic Clonidine Hydrochloride extended-release tablets in the American market after...
      Johnson multiple myeloma drug succeeds in first-line combination study

      Johnson multiple myeloma drug succeeds in first-line combination study

      Ruby Khatun Khatun23 Nov 2017 10:00 AM IST
      Johnson and Johnson's blockbuster multiple myeloma drug Darzalex when added to a standard therapy regimen reduced the risk of disease progression or...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok